Eyepoint Pharmaceuticals Inc (EYPT) financials · rev $31.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Eyepoint Pharmaceuticals Inc (EYPT) rev $31.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $31.4M | $43.3M |
| Operating Income | -$243.4M | -$145.9M |
| Net Income | -$232.0M | -$130.9M |
| EPS (Diluted) | -$3.17 | -$2.32 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $364.0M | $418.5M |
| Current Assets | $328.7M | $383.3M |
| Cash & Equivalents | $101.8M | $99.7M |
| Inventory | $1.81M | $2.31M |
| PP&E | $9.02M | $8.18M |
| Total Liabilities | $57.9M | $82.0M |
| Current Liabilities | $37.0M | $49.0M |
| Shareholders' Equity | $306.1M | $336.5M |
| Retained Earnings | -$1.10B | -$873.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$240.1M | -$126.2M |
| CapEx | $3.28M | $4.05M |
| Investing Cash Flow | $68.6M | -$219.4M |
| Financing Cash Flow | $173.6M | $164.0M |
| Net Change in Cash | $2.12M | -$181.6M |
| Free Cash Flow | -$243.4M | -$130.3M |
FAQ
What is EYPT P/E and revenue?
Eyepoint Pharmaceuticals Inc (EYPT) rev $31.4M.
What is EYPT revenue?
Eyepoint Pharmaceuticals Inc last cached revenue is $31.4M (FY2025).
Is EYPT profitable?
Eyepoint Pharmaceuticals Inc last cached net income is -$232.0M (FY2025).
What are EYPT total assets?
Eyepoint Pharmaceuticals Inc last cached total assets are $364.0M (FY2025).
What is EYPT free cash flow?
Eyepoint Pharmaceuticals Inc last cached free cash flow is -$243.4M (FY2025).
Not investment advice. Cached statements, not a live tape.